ArticleJournal of plastic and reconstructive surgery2026
Successful Treatment of Lymphocele after Inguinal Lymph Node Dissection with OK-432 Sclerotherapy: A Report of Two Cases.
Article in Journal of plastic and reconstructive surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comments to "Successful Treatment of Lymphocele After Inguinal Lymph Node Dissection with OK-432 Sclerotherapy: A Report of Two Cases".Journal of plastic and reconstructive surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymphocele is a frequent complication in the early postoperative period following lymph node dissection. In this study, we performed sclerotherapy with OK-432 (picibanil) in two cases of lymphocele after groin lymph node dissection. Case 1 involved a 55-year-old male patient who underwent bilateral groin lymph node dissection. A lymphocele developed in the groin after drain removal. The lymphocele in the left groin worsened after the patient resumed work. After four sessions of sclerotherapy with OK-432, the lymphocele resolved. Case 2 involved a 67-year-old male patient who also underwent bilateral groin lymph node dissection. The lymphocele in the left groin persisted despite the initial treatment, but disappeared after four sessions of sclerotherapy with OK-432. The treatment duration for cases 1 and 2 were 51 and 23 days, respectively. Both cases showed mild dermal back flow on lymphoscintigraphy several years after surgery. Sclerotherapy with OK-432 resulted in acceptable results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.